Search
for
Sort by
Research 30 of 677
- Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
- Proteomic Profiling of Central Centrifugal Cicatricial Alopecia Reveals Role of Humoral Immune Response Pathway and Metabolic Dysregulation
- Data from: Systemic humoral activation facilitates tissue regeneration by D-chiral biomaterial scaffolds
- Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
- Improved Humoral Immunity and Protection against Influenza Virus Infection with a 3d Porous Biomaterial Vaccine
- Systemic humoral activation facilitates tissue regeneration by D-chiral biomaterial scaffolds
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- Improved humoral immunity and protection against influenza virus infection with a 3D porous biomaterial vaccine
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- Safety of dermatologic medications in pregnancy and lactation
- Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab
- Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa
- S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version
- Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease
- Alopecia Areata following Adalimumab
- Alopecia Universalis Successfully Treated With Adalimumab
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab
- Adalimumab-related alopecia in a patient affected by psoriasis
- Adalimumab‐induced scalp psoriasis with severe alopecia
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients